Acer Therapeutics Inc (NASDAQ:ACER)

17.28
Delayed Data
As of Feb 23
 -0.88 / -4.83%
Today’s Change
5.70
Today|||52-Week Range
22.63
+24.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
AssetsCash3.4M2.8M1.8M8.4M
 
 
 
 
 
Short Term Investment Cash-2.4M-622.3K-998.3K8.2M
 
 
 
 
 
Cash & Short Term Investments3.4M2.8M1.8M8.4M
 
 
 
 
 
 
ReceivablesReceivables0.000.000.000.00--
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses259.9K187.4K106.1K836.8K
 
 
 
 
 
Current Assets3.7M3.0M1.9M9.2M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross3.2M----10.7K
 
 
 
Depreciation-3.2M0.000.00-5.6K
 
 
 
Intangible Assets0.000.000.007.8M
 
 
Other Assets111.6K49.9K49.9K7.8M
 
 
 
 
 
Total Assets3.9M3.1M2.0M17.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable378.0K0.000.000.00
 
 
Short Term Debt156.6K91.9K26.5K0.00
 
 
 
 
Accrued Expenses625.9K428.4K335.2K1.7M
 
 
 
 
 
Other Current Liabilities625.9K726.4K342.0K2.3M
 
 
 
 
 
Other Liabilities1.2M818.3K368.5K2.3M
 
 
 
 
 
 
Total LiabilitiesTotal Liabilities1.2M818.3K368.5K2.3M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity2.7M2.2M1.6M14.8M
 
 
 
 
 
Total Shareholder Equity2.7M2.2M1.6M14.8M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding689.6K739.4K739.4K6.5M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.